Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Crossflo Competition
Reply New Message
Prev Message Back To Forum Threaded View Next Message

RE: "Why then is Crossflo's projected 2009 revenue only $6 million?"

At least we have been given a revenue outlook. Assuming 35% expenses, we'd have a net of around $4 million; or about one cent per share EPS. Put a resonable P/E ratio to that 1 cent EPS and we could have a SP of 15 cents next year.

But then I'm assuming all other PTSC expenses are off-set by income. Another way to say that is, I'm assuming any other income will be consumed by PTSC's other expenses. A fair assumption for 2009?



1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply